{"status": "OK", "response": {"docs": [{"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "A brain-dead pregnant woman on life support has passed the milestone in her pregnancy where doctors believe the baby could realistically survive outside the womb, giving her family renewed hope. The woman, Susan Torres, 26, lost consciousness from a stroke on May 7 after aggressive melanoma spread to her brain.", "headline": {"main": "Brain-Dead Woman's Fetus Passes Milestone in Development"}, "abstract": "Doctors say brain-dead pregnant woman on life support has passed milestone in her pregnancy where they believe baby could realistically survive outside womb, Arlington, Va; Jason Torres says doctors say his wife Susan's brain functions stopped; she suffered stroke on May 7 after aggressive melanoma spread to her brain (M)", "print_page": "17", "word_count": "557", "_id": "4fd25c818eb7c8105d80a31c", "snippet": "A brain-dead pregnant woman on life support has passed the milestone in her pregnancy where doctors believe the baby could realistically survive outside the womb.", "source": "AP", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/21/health/21fetus.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "TORRES, JASON"}, {"name": "persons", "value": "TORRES, SUSAN"}, {"name": "glocations", "value": "ARLINGTON (VA)"}, {"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "DEATH AND DYING"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": null, "document_type": "article", "pub_date": "2005-07-21T00:00:00Z", "section_name": "Health"}, {"type_of_material": "News", "blog": [], "news_desk": "Thursday Styles", "lead_paragraph": "IN a country that takes pride in its multiethnicity, a strange-sounding beauty trend is picking up steam. Suddenly, a torrent of new face creams and gels are promising ''whiteness'' or ''lightness.'' Clinique makes Active White, Dior has DiorSnow and beginning in September, Shiseido's White Lucent line will be in stores. In the past year and a half, at least 30 such products have come on the market, according to Mintel's Global New Products Database, which tracks the cosmetics industry. Sephora stores have seen a 40 percent increase in sales of skin whitening and lightening products since the middle of last year, said Allison Slater, vice president of retail marketing for the beauty store chain.", "headline": {"main": "Trouble Spots Got You Down? Lighten Up", "kicker": "SKIN DEEP"}, "abstract": null, "print_page": "3", "word_count": 1308, "_id": "4fd2a8b68eb7c8105d89372f", "snippet": "Skin lightening products, which even out skin color and diminish dark spots, have flooded the marketplace.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/21/fashion/thursdaystyles/21skin.html", "multimedia": [{"url": "imagepages/2005/07/21/fashion/21skin_2.ready.html", "rank": "2", "height": 325, "width": 250, "legacy": {"MultimediaPopupHeight2": "325", "MultimediaUrl2": "imagepages/2005/07/21/fashion/21skin_2.ready.html", "MultimediaPopupWidth2": "250", "MultimediaType2": "Image"}, "type": "Image"}, {"url": "imagepages/2005/07/21/fashion/21skin_1.ready.html", "rank": "1", "height": 325, "width": 250, "legacy": {"MultimediaPopupWidth1": "250", "MultimediaPopupHeight1": "325", "MultimediaUrl1": "imagepages/2005/07/21/fashion/21skin_1.ready.html", "MultimediaType1": "Image"}, "type": "Image"}, {"url": "images/2005/07/21/fashion/skin.75.jpg", "subtype": "thumbnail", "legacy": {"hasthumbnail": "Y", "thumbnailheight": 75, "thumbnail": "images/2005/07/21/fashion/skin.75.jpg"}, "type": "image", "height": 75}], "subsection_name": null, "keywords": [{"name": "organizations", "value": "SEPHORA"}, {"name": "organizations", "value": "SHISEIDO"}, {"name": "organizations", "value": "LUCENT TECHNOLOGIES INCORPORATED"}, {"name": "subject", "value": "HORMONES"}, {"name": "subject", "value": "COSMETICS AND TOILETRIES"}, {"name": "subject", "value": "BIRTH CONTROL AND FAMILY PLANNING"}], "byline": {"person": [{"organization": "", "role": "reported", "rank": 1, "firstname": "Sally", "lastname": "WADYKA"}], "original": "By SALLY WADYKA"}, "document_type": "article", "pub_date": "2005-07-21T00:00:00Z", "section_name": "Style"}, {"type_of_material": "Correction", "blog": [], "news_desk": "Metropolitan Desk", "lead_paragraph": "An article yesterday about the Food and Drug Administration's decision to change the label of the abortion drug Mifeprex after the deaths of two women in California, to include a warning of possible bacterial infection, misstated its generic name. It is mifepristone. (Misoprostol is the drug taken after mifepristone to induce abortion early in pregnancy.)", "headline": {"main": "Corrections"}, "abstract": "Correction of July 20 article on Food and Drug Administration decision to change label of abortion drug Mifeprex after deaths of two women; its generic name is mifepristone", "print_page": "2", "word_count": 55, "_id": "4fd25f0d8eb7c8105d80eb58", "snippet": "An article yesterday about the Food and Drug Administration's decision to change the label of the abortion drug Mifeprex after the deaths of two women in California, to include a warning of possible bacterial infection, misstated its generic name. It...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9C01E5DD153CF932A15754C0A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "MIFEPREX (RU-486) (DRUG)"}, {"name": "subject", "value": "GENERIC AND BRAND NAME PRODUCTS"}, {"name": "subject", "value": "ABORTION"}, {"name": "subject", "value": "LABELING AND LABELS"}, {"name": "subject", "value": "CORRECTION STORIES"}], "byline": null, "document_type": "article", "pub_date": "2005-07-21T00:00:00Z", "section_name": "Corrections; New York and Region"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "In the late 1980's and early 1990's, lawyers for the first Bush administration repeatedly argued before the Supreme Court for the reversal or rollback of Roe v. Wade, the 1973 decision recognizing a constitutional right to abortion. Protests roiled the streets, and blockades shook the abortion clinics. It was a time when clear lines were drawn. And, abortion rights leaders argued Wednesday, there was little question about which side John G. Roberts was on -- he was the principal deputy in the solicitor general's office, helping to write one brief that declared, ''We continue to believe that Roe was wrongly decided and should be overruled.''", "headline": {"main": "Cold Paper Trail Leads Some to Scrutinize Nominee's Past Words on Abortion", "kicker": "COURT IN TRANSITION: ABORTION"}, "abstract": "Supreme Court nominee John G Roberts has left little in way of paper trail on abortion issue in recent years; this heightens focus on his work as deputy solicitor general in first Bush administration, when he repeatedly argued before Supreme Court for reversal or rollback of Roe v Wade; at issue is whether he was simply representing his client, the government, when he took that stand, or was showing his own beliefs about constitutional right to abortion; photo (M)", "print_page": "22", "word_count": 1221, "_id": "4fd25c818eb7c8105d80a321", "snippet": "WASHINGTON, July 20 - In the late 1980's and early 1990's, lawyers for the first Bush administration repeatedly argued before the Supreme Court for the reversal or rollback of Roe v. Wade, the 1973 decision recognizing a constitutional right to...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/21/politics/21abort.html", "multimedia": [{"width": 250, "url": "imagepages/2005/07/20/politics/20050721_ABORT_GRAPHIC.html", "rank": "1", "height": 325, "caption": "A Legal Argument", "legacy": {"MultimediaPopupWidth1": "250", "MultimediaUrl1": "imagepages/2005/07/20/politics/20050721_ABORT_GRAPHIC.html", "MultimediaPopupHeight1": "325", "MultimediaType1": "Image", "MultimediaHeadline1": "A Legal Argument"}, "type": "Image"}], "subsection_name": null, "keywords": [{"name": "persons", "value": "BUSH, GEORGE"}, {"name": "persons", "value": "ROBERTS, JOHN G"}, {"name": "persons", "value": "ROBERTS, JOHN G JR"}, {"name": "glocations", "value": "UNITED STATES"}, {"name": "organizations", "value": "SUPREME COURT"}, {"name": "subject", "value": "ABORTION"}, {"name": "subject", "value": "LAW AND LEGISLATION"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Robin", "rank": 1, "lastname": "TONER"}], "original": "By ROBIN TONER; David D. Kirkpatrick and Eric Lichtblau contributed reporting for this article"}, "document_type": "article", "pub_date": "2005-07-21T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "Letter", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "To the Editor: You report that John G. Roberts, as deputy solicitor general, argued in 1990 in favor of a government regulation banning abortion-related counseling in federally financed family planning programs and that he also helped write a brief then that restated the first Bush administration's opposition to Roe v. Wade.", "headline": {"main": "A New Face for the Court: Meeting Judge Roberts"}, "abstract": null, "print_page": "28", "word_count": 143, "_id": "4fd25f0d8eb7c8105d80eb77", "snippet": "To the Editor:     You report that John G. Roberts, as deputy solicitor general, argued in 1990 in favor of a government regulation banning abortion-related counseling in federally financed family planning programs and that he also helped write a...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9F01E5DD173FF932A15754C0A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": null, "document_type": "article", "pub_date": "2005-07-21T00:00:00Z", "section_name": "Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Children born prematurely at weights of 2.2 pounds or less during the 1990's have high rates of mental and physical disability, despite advances in treatment that doctors had hoped would improve their conditions, researchers are reporting today. Although such infants were much more likely to survive than those born in previous decades -- the survival rate was 70 percent in the 1990's, compared with 50 percent in the 1970's and 80's -- they were just as likely to suffer from significant disabilities.", "headline": {"main": "Very Premature Babies Found Still at Risk"}, "abstract": null, "print_page": "12", "word_count": 706, "_id": "4fd260f38eb7c8105d811628", "snippet": "Children born prematurely at weights of 2.2 pounds or less during the 1990's had high rates of mental and physical disability, a report states.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/20/national/20birth.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "BABIES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Denise", "rank": 1, "lastname": "GRADY"}], "original": "By DENISE GRADY"}, "document_type": "article", "pub_date": "2005-07-20T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "John G. Roberts has been on the federal bench for two years, but he made his reputation on the other side of it, as one of the great Supreme Court advocates of his generation. He last appeared before the Supreme Court in November 2002, six months before the Senate confirmed his nomination to the United States Court of Appeals for the District of Columbia Circuit.", "headline": {"main": "A Career Largely on One Side of the Bench and Involving a Wide Variety of Issues", "kicker": "COURT IN TRANSITION: THE RECORD"}, "abstract": null, "print_page": "17", "word_count": 1110, "_id": "4fd24acb8eb7c8105d7e98a6", "snippet": "John G. Roberts has been on the federal bench for two years, but he made his reputation as one of the great Supreme Court advocates of his generation.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/20/politics/politicsspecial1/20cases.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "organizations", "value": "SUPREME COURT"}, {"name": "subject", "value": "POLITICS AND GOVERNMENT"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Adam", "rank": 1, "lastname": "LIPTAK"}], "original": "By ADAM LIPTAK"}, "document_type": "article", "pub_date": "2005-07-20T00:00:00Z", "section_name": "U.S."}, {"type_of_material": "News", "blog": [], "news_desk": "National Desk", "lead_paragraph": "Two more California women have died after taking abortion pills, and federal drug regulators say they suspect bacterial infections as the cause. As a result, the drug's label will be changed to warn women and doctors to watch out for signs of an unusual infection that is not always accompanied by fever, the Food and Drug Administration announced Tuesday. Five women in the United States have now died after taking abortion pills; four of them most likely suffered lethal bacterial infections, said Dr. Steven Galson, director of the agency's center for drugs.", "headline": {"main": "2 More Women Die After Abortion Pills"}, "abstract": null, "print_page": "18", "word_count": 542, "_id": "4fd2a8b68eb7c8105d89370d", "snippet": "Two more California women have died after taking abortion pills, and federal drug regulators say they suspect bacterial infections as the cause. As a result, the drug's label will be changed to warn women and doctors to watch out for signs of an...", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/fullpage.html?res=9A0CE3DC143CF933A15754C0A9639C8B63", "multimedia": [], "subsection_name": null, "keywords": [], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Gardiner", "rank": 1, "lastname": "HARRIS"}], "original": "By GARDINER HARRIS"}, "document_type": "article", "pub_date": "2005-07-20T00:00:00Z", "section_name": "Health; U.S."}, {"type_of_material": "Editorial", "blog": [], "news_desk": "Editorial Desk", "lead_paragraph": "Gov. George Pataki will soon have a chance to sign a bill that would give New York's women the chance to get emergency contraceptives without a prescription. The governor, who has apparently been eyeing the possibilities of a 2008 run for president, may be thinking about the politics of this bill more than the science. If so, he should think about how this law could help cut down on unintended pregnancies for all women in New York state. Over the years, Mr. Pataki has been recognized, especially among Republican women, as a politician who understands the need for women to have access to contraceptives. He has also made his name as a pro-choice Republican, approving, for example, a way for low-income women to gain access to the abortion pill, RU-486. Trimming those sails now for political purposes would not win over the hardest of the anti-abortion conservatives in his own party. It would merely offend his moderate Republican friends.", "headline": {"main": "Governor Pataki and Women's Rights", "kicker": "Editorial"}, "abstract": "Editorial urges Gov George Pataki to sign bill that would give New York's women chance to get emergency contraceptives without prescription", "print_page": "20", "word_count": 416, "_id": "4fd24caa8eb7c8105d7ec236", "snippet": "The governor must sign a bill that would give New York's women the chance to get emergency contraceptives without a prescription.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/19/opinion/19tue3.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "persons", "value": "PATAKI, GEORGE E"}, {"name": "glocations", "value": "NEW YORK STATE"}, {"name": "glocations", "value": "NEW YORK CITY"}, {"name": "organizations", "value": "FOOD AND DRUG ADMINISTRATION"}, {"name": "subject", "value": "ABORTION"}, {"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "EDITORIALS"}, {"name": "subject", "value": "DRUGS (PHARMACEUTICALS)"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "LAW AND LEGISLATION"}, {"name": "subject", "value": "BIRTH CONTROL AND FAMILY PLANNING"}], "byline": null, "document_type": "article", "pub_date": "2005-07-19T00:00:00Z", "section_name": "Health; Opinion"}, {"type_of_material": "News", "blog": [], "news_desk": "Health & Fitness", "lead_paragraph": "When morning-after pills become more easily available, do women become less diligent about using birth control? Apparently not, reports a new study in the medical journal BMJ, which looked at what happened in Britain after it became legal to buy emergency contraception without a prescription.", "headline": {"main": "The Night Before the Morning After", "kicker": "VITAL SIGNS: BEHAVIOR"}, "abstract": null, "print_page": "6", "word_count": 266, "_id": "4fd25c818eb7c8105d80a2f1", "snippet": "When morning-after pills become more easily available, do women become less diligent about using birth control? Apparently not, says a new study.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://www.nytimes.com/2005/07/19/health/19beha.html", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "PREGNANCY AND OBSTETRICS"}, {"name": "subject", "value": "BIRTH CONTROL AND FAMILY PLANNING"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Eric", "rank": 1, "lastname": "Nagourney"}], "original": "By Eric Nagourney"}, "document_type": "article", "pub_date": "2005-07-19T00:00:00Z", "section_name": "Health"}], "meta": {"hits": 13, "offset": 0, "time": 187}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}